Peter Jelley Sells 20,000 Shares of Andlauer Healthcare Group Inc. (TSE:AND) Stock

Andlauer Healthcare Group Inc. (TSE:AND) Director Peter Jelley sold 20,000 shares of the business’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of C$38.70, for a total value of C$774,000.00.

Andlauer Healthcare Group Stock Performance

Shares of AND opened at C$38.96 on Friday. The business’s fifty day simple moving average is C$40.05 and its two-hundred day simple moving average is C$42.98. The company has a market cap of C$772.58 million, a price-to-earnings ratio of 24.97 and a beta of 0.71. The company has a current ratio of 2.36, a quick ratio of 1.66 and a debt-to-equity ratio of 27.33. Andlauer Healthcare Group Inc. has a 12 month low of C$36.76 and a 12 month high of C$53.00.

Andlauer Healthcare Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, October 16th. Stockholders of record on Friday, September 29th were issued a dividend of $0.09 per share. This represents a $0.36 annualized dividend and a dividend yield of 0.92%. This is a boost from Andlauer Healthcare Group’s previous quarterly dividend of $0.08. The ex-dividend date was Thursday, September 28th. Andlauer Healthcare Group’s dividend payout ratio is presently 20.51%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on AND. Royal Bank of Canada cut their price objective on Andlauer Healthcare Group from C$45.00 to C$41.00 and set a “sector perform” rating for the company in a report on Monday, November 6th. Stifel Nicolaus lowered their price target on Andlauer Healthcare Group from C$60.00 to C$55.00 in a research report on Monday, November 6th. TD Securities lowered their price target on Andlauer Healthcare Group from C$56.00 to C$51.00 and set a “buy” rating for the company in a research report on Monday, November 6th. Finally, Scotiabank decreased their target price on Andlauer Healthcare Group from C$48.00 to C$44.00 and set a “sector perform” rating for the company in a research report on Wednesday, September 27th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, Andlauer Healthcare Group currently has a consensus rating of “Moderate Buy” and an average target price of C$51.68.

About Andlauer Healthcare Group

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.